Story City, IA, United States of America

John Rathmacher

This inventor holds 22 USPTO granted patents and 23 published patent applications, plus 6 CIPO patents and 8 EPO patents, primarily in Nutritional Interventions. Top assignees: Metabolic Technologies, Inc., Mti Biotech, Inc., Tsi Group Co., Ltd.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Rathmacher. Retrieved from https://idiyas.com/inventor/john-rathmacher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 23)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 10)

EPO Patents = 8 (Patent Applications = 18)

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 39(Granted Patents)

Company Filing History:

17 out of 19

Metabolic Technologies, Inc.

Metaolic Technologies, LLC

patent

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Nutritional Intervention

HMB

Liver Disease

Fibrosis

Nonalcoholic Fatty Liver Disease

Probiotics

Adenosine Triphosphate

Muscular Function

Autophagy

Lipophagy

Vitamin D Stability

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636269 - Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liver (2026-05-26),

2. 12383515 - Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver (2025-08-12),

3. 12370159 - Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics (2025-07-29),

4. 12251393 - Compositions containing adenosine triphosphate (ATP) and methods of use (2025-03-18),

5. 12220391 - Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy (2025-02-11),

6. 12161654 - Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB) (2024-12-10),

7. 11666593 - Compositions containing adenosine triphosphate (ATP) and methods of use (2023-06-06),

8. 11547713 - Nutritional intervention for improving muscular function and strength (2023-01-10),

9. 11406609 - Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy (2022-08-09),

10. 11173167 - Nutritional intervention for improving muscular function and strength (2021-11-16),

11. 10925845 - Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB) (2021-02-23),

12. 10888576 - Composition of HMB and ATP and methods of use (2021-01-12),

13. 10772856 - Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for decreasing fat mass (2020-09-15),

14. 10682363 - Nutritional intervention for improving muscular function and strength (2020-06-16),

15. 10213399 - Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy (2019-02-26),

Title: **John Rathmacher: A Pioneer in Nutritional Innovations**

Introduction

John Rathmacher, an accomplished inventor based in Story City, Iowa, has made significant contributions to the field of nutritional science. With a remarkable portfolio of 19 patents, his innovative work focuses on enhancing bioavailability and health benefits through advanced compositions.

Latest Patents

Among his latest patents, Rathmacher introduced groundbreaking compositions involving adenosine triphosphate (ATP). His invention highlights the use of ATP as an absorption enhancer when combined with various nutritional materials such as nutrients, proteins, peptides, vitamins, phytochemicals, minerals, fatty acids, or amino acids. Moreover, he outlined methods for administering ATP or adenosine to improve the bioavailability of these nutritional materials.

Another notable patent involves the use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy. In this patent, Rathmacher provides a unique composition comprising HMB and methods for its administration in animals, aiming to treat, prevent, inhibit, slow, or reduce autophagy-related conditions or diseases.

Career Highlights

Throughout his career, Rathmacher has worked with leading companies in the industry, including Metabolic Technologies, Inc. and Tsi Group Co., Ltd. His work at these organizations has been an essential part of his journey in exploring innovative solutions in nutrition and health.

Collaborations

John Rathmacher has collaborated with impressive minds in the field, including coworkers Shawn Baier and Naji N Abumrad. These partnerships have been instrumental in advancing his research and broadening the impact of his inventions.

Conclusion

John Rathmacher stands out as a notable inventor whose work has the potential to revolutionize nutritional science. His latest patents on ATP and HMB not only reflect his innovative spirit but also signify a meaningful contribution to enhancing human health and wellness through improved nutritional formulations.

Profile summary based on public USPTO records.